The executive management team is drawn from a breadth of disciplines within the life science, diagnostics and consumer electronics fields.

Dr. Trevor Hawkins Chairman and CEO.

Dr. Trevor L. Hawkins. Chairman and CEO. Dr. Hawkins has built a career in the life science and healthcare industry holding several high profile commercial and technical roles. Prior to joining Progentech, he was CEO of Royal Philips Molecular Healthcare business and has also been the CEO of GE's Molecular Diagnostics business. Prior to his move into the commercial sector, Dr Hawkins was Director of the Joint Genome Institute, the US DOE's Human Genome Program. While an Assistant Professor at the Whitehead Institute, Dr. Hawkins invented SPRI, the magnetic particle approach that is the basis for much of the developments in the field over the past ten years.

Steve Yu Founder, President and COO.

Steve is the founder of Progentech Limited and is now serving as the President and COO. Steve served as the Chairman of the Board and CEO at Progentech from May 2005 to March 2008. He is the primary inventor of the close-loop cassette technologies that are currently used on the company’s NAP platform products. Prior to Progentech, Steve worked at various startup companies in both high-tech and Bio-tech industries with over 15 years of experiences. Steve founded Yustek Solution, a system electronic design consulting firm in Silicon Valley. Steve also held a range of system design project management and engineering positions with Cepheid working on the GeneXpert platform. Prior to Cepheid, Steve was a senior system architect & project manager at 3Com. Steve also held a number of senior engineering positions with SAN Valley System, Cypress Semiconductor, ICWorks, Chrontel, and NASA. Steve earned his BS degree in Electrical Engineering & Mathematic from San Jose State University.

Dr. Jesus Ching Founder, Chief Science Officer.

Jesus Ching, Ph.D., is a co-founder and chief science officer of Progentech Limited. In 2005 where he served as the Vice President of Research and Development. Prior to Progentech, Dr. Ching was the Director of Research and Development at Cepheid (Sunnyvale, CA) where he successfully co-invented key technologies (7 patents) and managed the development of molecular diagnostic products in oncology and infectious disease. Dr Ching also facilitated in the launching of ProteinChips® (i.e., biochips) at Ciphergen Biosystems in 1998. Ciphergen Biosystems (Fremont, CA) was purchased by BioRad in 2007. Dr. Ching developed the initial chemistries for ProteinChips® while at University of California at Davis and Baylor College of Medicine (Houston, TX) as a postgraduate and graduate student, respectively. Dr. Ching has a Ph.D. in Biochemistry from Baylor University (Waco, TX) in 1996.

Dr. Paul Richardson Vice President R&D

Dr. Richardson received his BA in biology and chemistry from Middlebury College in Vermont.  He holds a Ph.D. in Molecular Biology from Boston University and did postdoctoral work at Children's Hospital and Harvard Medical School in Boston.  After working for two biotech start-up companies in Boston, Dr. Richardson joined the MIT/Whitehead Genome Center as the production manager. Dr. Richardson joined the US Department of Energy's Joint Genome Institute in 1998. While working on the Human Genome Project and beyond, Dr. Richardson led groups devoted to improving and adopting the newest sequencing technologies. Dr. Richardson also led the JGI Microbial Program which was responsible for producing several hundred bacterial and archeal genomes. He joins Progentech with over 15 years of experience in the genomics life sciences field.

David Hu Vice President Engineering

David is the VP of engineering in Progentech since April in 2008. David came back to China from United States in 2001 and has since founded or co-founded 3 companies in China and worked as senior management roles for the past 7 years. In 2003, David founded Chipnuts Technology that specializes in IC design for mobile and consumer electronics. Chipnuts has grown to become the leading multimedia IC provider to Chinese manufacturers with over 250 employees. Prior to coming back to China in 2001, David worked for various senior engineering roles at SAN Valley System, COM21, Philips, Avaya for over 10 years period in Silicon Valley area. David earned his BS in Electrical Engineering from Santa Clara University, California.

Sarah Wenning Vice President US Operations

Sarah Wenning is the VP, US Operations at Progentech Limited.  Sarah is responsible for operations and support functions at the Emeryville,California site.  She previously worked as the Biosciences Deputy Associate Director for Operations at the Lawrence Livermore National Laboratory, and as the Operations Department Head for the DOE's Joint Genome Institute.  She holds a degree from the University of Wisconsin - Madision in Economics and English.

Dylan Bird Director, Business Development

Dylan Bird joined Progentech in May of 2008 and is the Director of Business Development.  Mr. Bird is accountable for global strategy and business development activities.  Prior to joining Progentech, Mr. Bird was an investment professional at Bay City Capital and was responsible for developing financial analyses and conducting research for Bay City Capital's venture investments and related activities. He previously worked in the Research and Development group of Posit Science Corporation, a San Francisco based neurotechnology start-up company. Prior to Posit, Mr. Bird was a Robert T. Jones graduate fellow at the University of St. Andrews and holds a degree from Emory University in Neuroscience and French Literature.